<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04696926</url>
  </required_header>
  <id_info>
    <org_study_id>CIL 2019-48</org_study_id>
    <nct_id>NCT04696926</nct_id>
  </id_info>
  <brief_title>Five-year Outcomes of Rapid-deployment Aortic Valve Replacement With the Edwards Intuity TM Valve</brief_title>
  <official_title>Five-year Outcomes of Rapid-deployment Aortic Valve Replacement With the Edwards Intuity TM Valve: a Single-center Prospective Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique Hopitaux De Marseille</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique Hopitaux De Marseille</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Objectives:&#xD;
&#xD;
      This report presents 5-year outcomes of the rapid-deployment Edwards Intuity TM valve in a&#xD;
      single-center prospective study.&#xD;
&#xD;
      Methods:&#xD;
&#xD;
      All consecutive patients who underwent an aortic valve replacement with an Edwards Intuity TM&#xD;
      bioprosthesis at La Timone Hospital, Marseille, France, were prospectively included between&#xD;
      July 2012 and June 2015 and were followed for 5 years. The primary outcome was overall&#xD;
      mortality at 5 years.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">April 1, 2019</start_date>
  <completion_date type="Actual">December 30, 2020</completion_date>
  <primary_completion_date type="Actual">September 1, 2020</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>5-year overall mortality</measure>
    <time_frame>5 years</time_frame>
    <description>overall mortality</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">170</enrollment>
  <condition>Severe Aortic Valve Disease</condition>
  <arm_group>
    <arm_group_label>patients who underwent an aortic valve replacement</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Edwards Intuity TM Valve implantation</intervention_name>
    <description>aortic valve replacement with an Edwards Intuity TM bioprosthesis</description>
    <arm_group_label>patients who underwent an aortic valve replacement</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        170 consecutive patients who underwent an aortic valve replacement with an Edwards Intuity&#xD;
        TM bioprosthesis at La Timone Hospital, Marseille, France, were prospectively included&#xD;
        between July 2012 and June 2015 and were followed for 5 years.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consecutive patients implanted by the Intuity TM bioprosthesis&#xD;
&#xD;
          -  For severe aortic valve stenosis or severe aortic regurgitation&#xD;
&#xD;
          -  Including reoperation and combined surgery&#xD;
&#xD;
          -  Between July 2012 and June 2015&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  absence of patient's authorization for anonymous publication of their clinical data&#xD;
             for research purposes&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Assistance Publique HÃ´pitaux de Marseille</name>
      <address>
        <city>Marseille</city>
        <zip>13005</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2021</verification_date>
  <study_first_submitted>January 4, 2021</study_first_submitted>
  <study_first_submitted_qc>January 5, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">January 6, 2021</study_first_posted>
  <last_update_submitted>January 5, 2021</last_update_submitted>
  <last_update_submitted_qc>January 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">January 6, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>severe aortic stenosis</keyword>
  <keyword>severe aortic regurgitation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

